InsidersTradesSigma
Lincoln Pharmaceuticals Limited: management transactions · India · SEBI (PIT + SAST)
SEBI:lincoln-pharmaceuticals-limitedIN·SEBI (PIT + SAST)Mcap 11.0Bn€
Browse the full directors' dealings record of Lincoln Pharmaceuticals Limited, a listed equity based in India. Shares are quoted on IN IN, under the oversight of SEBI (PIT + SAST). Market capitalisation: €11bn. The latest transaction was reported on 6 June 2024 (Purchase). Among the most active insiders: Munjal Mahendrabhai Patel. Every trade is accessible without an account.
137
Insider Decl.
0
Thresholds
€15m
131 ops.
Buy Volume
€2m
6 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
678.90 €
Income statement
Revenue6.23 Bn€
Gross profit3.32 Bn€53% margin
Net income823.5 M€13.2% margin
Balance sheet & cash
Market cap11.05 Bn€
Total debt10.7 M€
Free Cash Flow737.7 M€
Last declaration on 6 June 2024
Declarations137 total
Executives●Purchase0SEBI
€80,25913,500 shares@ €5.9451
Equity Shares
SEBI:2ca919135ef08c3413a0afd0274537f89e53bc25·
Ideal exit: 1 Mar 2025 (T+270)
Executives●Purchase0SEBI
€93,76915,000 shares@ €6.2513
Equity Shares
SEBI:fffe31cdb6fe15868353c446cbdbff67454b23ba·
Ideal exit: 25 Feb 2025 (T+270)
Executives●Purchase0SEBI
€125,28820,000 shares@ €6.2644
Equity Shares
SEBI:66afd8c29418ca07eff03dadca13cc87feae9524·
Ideal exit: 28 Feb 2025 (T+270)
Executives●Sale0SEBI
€8,1511,000 shares@ €8.1514
Equity Shares
SEBI:da764219cb9bd4fe3172c42348903d43e666e5f8·
Executives●Sale0SEBI
€8,2551,000 shares@ €8.255
Equity Shares
SEBI:e435230cbd396eebb77476731e4f8535fa2ef364·
Executives●Sale0SEBI
€12,3191,500 shares@ €8.2127
Equity Shares
SEBI:6dd714e90b4e5b2f5b413baa25947f3fdc0faee4·
Executives●Purchase0SEBI
€143,21220,000 shares@ €7.1606
Equity Shares
SEBI:02bd575e10a0c277f448671a570daaf779ccc731·
Ideal exit: 12 Nov 2024 (T+270)
Executives●Sale0SEBI
€2m293,100 shares@ €5.7046
Equity Shares
SEBI:b37cdd8ba2f94d5a49fb74a97839e7c5c1df993b·
Executives●Purchase0SEBI
€2m293,100 shares@ €5.7046
Equity Shares
SEBI:847f5a62d0394a89682a0a71b94a150697e75368·
Ideal exit: 22 Jun 2024 (T+270)
Executives●Purchase0SEBI
€264,38644,800 shares@ €5.9015
Equity Shares
SEBI:25455e6c9d59fbc4556eb16be1c020f306f9e31f·
Ideal exit: 3 Jun 2024 (T+270)
Executives●Purchase0SEBI
€223,46338,000 shares@ €5.8806
Equity Shares
SEBI:89ef68d5704818bd3c55d342421ea70dd5de2e94·
Ideal exit: 1 Jun 2024 (T+270)
Executives●Purchase0SEBI
€106,60918,200 shares@ €5.8576
Equity Shares
SEBI:08bbcd909563805e6bceef2a07fd30e36f3d77b8·
Ideal exit: 1 Jun 2024 (T+270)
Executives●Purchase0SEBI
€167,24929,300 shares@ €5.7082
Equity Shares
SEBI:313568328def5a73081ff07d481ab2df40853c3e·
Ideal exit: 28 May 2024 (T+270)
Executives●Purchase0SEBI
€162,89728,300 shares@ €5.7561
Equity Shares
SEBI:74e8cc57a69f0f27dfb7051e0b5e7d192e315d09·
Ideal exit: 28 May 2024 (T+270)
Executives●Purchase0SEBI
€161,81728,300 shares@ €5.7179
Equity Shares
SEBI:888fd97e4c866e173c4e12adbf737214110e64a7·
Ideal exit: 26 May 2024 (T+270)
Executives●Purchase0SEBI
€166,13129,500 shares@ €5.6316
Equity Shares
SEBI:a1b86027e285537f567b2b0dfc2bbd709c3d47fd·
Ideal exit: 25 May 2024 (T+270)
Executives●Purchase0SEBI
€164,78629,700 shares@ €5.5484
Equity Shares
SEBI:028d49e288d28ea3a831ecf51dacf7bf8c60fef7·
Ideal exit: 24 May 2024 (T+270)
Executives●Purchase0SEBI
€166,60230,500 shares@ €5.4624
Equity Shares
SEBI:6bfb8a52ed6a296f3110f9272d01061514538668·
Ideal exit: 20 May 2024 (T+270)
Executives●Purchase0SEBI
€166,98131,000 shares@ €5.3865
Equity Shares
SEBI:82b8ca8c3419360c37020cc875d27772c2eeef0d·
Ideal exit: 21 May 2024 (T+270)
Executives●Purchase0SEBI
€164,50331,500 shares@ €5.2223
Equity Shares
SEBI:09b844d033f8e1c1c2e66dc292e3dc5b93d70ad8·
Ideal exit: 18 May 2024 (T+270)
Executives●Purchase0SEBI
€166,68632,200 shares@ €5.1766
Equity Shares
SEBI:158ffa5c9feef81e5994b79fb6146e479ce55167·
Ideal exit: 19 May 2024 (T+270)
Executives●Purchase0SEBI
€100,06422,000 shares@ €4.5484
Equity Shares
SEBI:becad599e80f055c8e02ae76b6eac9e9b64a17c4·
Ideal exit: 22 Mar 2024 (T+270)
Executives●Purchase0SEBI
€45,15410,000 shares@ €4.5154
Equity Shares
SEBI:17ad00b622914654a2fbb428a0bbb1cf386b8109·
Ideal exit: 23 Mar 2024 (T+270)
Executives●Purchase0SEBI
€107,79723,500 shares@ €4.5871
Equity Shares
SEBI:857af677030321f6228da5beb9f99deadc0968a7·
Ideal exit: 22 Mar 2024 (T+270)
Executives●Purchase0SEBI
€110,37725,000 shares@ €4.4151
Equity Shares
SEBI:23784edf76b698e75ba1f012e23e7112864b1fbe·
Ideal exit: 15 Mar 2024 (T+270)
25 of 137 declarations